Navigation Links
Pharmacyclics to Present and Webcast at Upcoming Life Sciences Investor Conferences
Date:9/3/2009

SUNNYVALE, Calif., Sept. 3 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune mediated diseases and cancer, today announced that Dr. Glenn Rice, President and COO, will provide a business overview at the following conferences:

-- Thomas Weisel Partners 2009 Healthcare Conference at the Four Seasons Hotel in Boston on Wednesday, September 9th at 3:50 p.m. EDT.

-- Rodman & Renshaw 11th Annual Healthcare Conference at the Palace Hotel in New York on Thursday, September 10th at 12:05 p.m. EDT.

There will be a live webcast of the presentations, which will be accessible through a link posted on the investor relations / events & webcasts section of the PCYC website, please go to http://ir.pharmacyclics.com/events.cfm. The webcasts will be available for replay through October 10th, 2009.

About Pharmacyclics

Pharmacyclics((R)) is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of immune mediated disease and cancer. The purpose of the company is to create a profitable business by generating income from products it develops, licenses and commercializes, either with one or several potential partners or alone as may best forward the economic interest of its stakeholders. The Company endeavors to create novel, patentable, differentiated products that have the potential to significantly improve the standard of care in the markets it serves. Presently, Pharmacyclics has four product candidates in c
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Pharmacyclics, Inc. Rights Offering Oversubscribed
2. Pharmacyclics Announces Subscription Price for Rights Offering
3. Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference
4. Pharmacyclics Files Registration Statement for Rights Offering
5. Pharmacyclics Reports Second Quarter Fiscal 2009 Financial Results
6. Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth
7. Pharmacyclics Secures $5.0 Million in Debt Financing
8. Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
9. Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results
10. Pharmacyclics Announces It Received Nasdaq Notice of Compliance
11. Pharmacyclics Announces It Received Nasdaq Notification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 ... international investment research firm, announces the initiation ... a French biopharmaceutical company developing and marketing ... care indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... comprehensive report examining the investment merits of ...
(Date:6/18/2013)... 2013  Techne Corporation (NASDAQ: TECH ... to acquire 100% ownership of Bionostics Holdings Limited ... is a global leader in the development, manufacture ... proper operation of in vitro diagnostic ... blood glucose and blood gas testing.  Biosnostics has ...
(Date:6/18/2013)... , June 18, 2013   Lexicon ... a biopharmaceutical company focused on discovering breakthrough treatments ... Northcott has joined the company as its ... Mr. Northcott brings extensive commercial experience to Lexicon, ... a variety of therapeutic areas. Mr. ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Inflamax ... Proof of Concept and Phase I-IV clinical trials, ... alliance with Northern Air Environmental Technologies (NAET), a ... the deployment, monitoring, and servicing of mobile Environmental ... Ocular clinical trials. , Inflamax ...
Breaking Biology Technology:Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3Inflamax Research Inc. Enters Strategic Partnership with Northern Air Environmental Technologies Inc. 2Inflamax Research Inc. Enters Strategic Partnership with Northern Air Environmental Technologies Inc. 3
... CLAREMONT, Calif., Oct. 25, 2011 Keck Graduate Institute (KGI) ... speaker at the upcoming Pichia 2012 conference from February 23 ... spent years conducting internationally-renowned research on the development and use ... system for the production of recombinant proteins. At ...
... JUNCTION, N.J., Oct. 25, 2011 Insmed Incorporated (Nasdaq CM: ... Tuesday, November 8 th , 2011, at 8:30 AM ET, ... 2011.  Insmed intends to issue its quarterly financial results press ... To participate in the live conference call, ...
... Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the ... on operations and disclosed the outcome of a strategic ... management and AMT,s Board of Directors that enables the ... development. The CHMP,s recent opinion, while not approving Glybera®, ...
Cached Biology Technology:KGI Professor Cregg to Be Featured Speaker at Pichia 2012 Conference 2Insmed to Host 2011 Third Quarter Earnings Conference Call 2Insmed to Host 2011 Third Quarter Earnings Conference Call 3Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline 2Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline 3Amsterdam Molecular Therapeutics Provides Operations Update & Strategic Review of Pipeline 4
(Date:6/17/2013)... Biochemical and Biophysical Research Communications , Saint Louis ... previously unknown viruses. The technique offers the potential to ... identified a particular virus as the likely source of ... scientists use blood serum as a biological source to ... complete deciphering of the human genome, SLU researchers used ...
(Date:6/17/2013)... bacteria, and algae, is a common component of sugar-free ... the medical field it,s approved by the FDA ... used during surgery as a substance that opens the ... , Now Profs. Ehud Gazit and Daniel Segal of ... and the Sagol School of Neuroscience, along with their ...
(Date:6/17/2013)... CORVALLIS, Ore. Amphibian populations are declining worldwide and ... be spread by bullfrogs, but a two-year study shows ... suggestions that bullfrogs are a tolerant carrier host that ... frogs from eggs in controlled experimental conditions, they found ... dendrobatidis , also called Bd or a chytrid fungus, ...
Breaking Biology News(10 mins):Saint Louis University researchers discover a way to detect new viruses 2Saint Louis University researchers discover a way to detect new viruses 3Artificial sweetener a potential treatment for Parkinson's disease 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2
... International Scientific Congress attended by more than 2,500 delegates ... The conclusions will be published as a full report ... the Danish Prime Minister Mr. Anders Fogh Rasmussen today. ... Conference in December 2009 and will hand over the ...
... have taken a first look at the broad genetic ... Although scientists have known for more than a century ... are likely to suffer from low reproductive success, the ... still the subject of debate. The new study, ...
... An international research team, involving Professor Rajeev Ahuja at ... to understand the mechanism behind the catalytic effects of ... a synergistic approach and the results, published this week ... Letters , will fasten efforts to develop new catalysts. ...
Cached Biology News:'Climate change: Global risks, challenges and decisions' 2'Climate change: Global risks, challenges and decisions' 3Researchers take first look at the genetic dynamics of inbreeding depression 2Researchers take first look at the genetic dynamics of inbreeding depression 3Revealing new applications for carbon nanomaterials in hydrogen storage 2
... the professional, student, or faculty researcher, the new ... your research and improve the quality of your ... the edge that researchers using LI-COR DNA analysis ... The 4300 System is a third generation instrument ...
This free-standing work station safely ventilates fumes upwards, away from the work surface. Optional Exhaust Purification System features bonded charcoal filters that remove organic chemical vapors ...
... testing at various temperatures, this chamber ... a clean heating unit to maintain ... 140F. Transparent panels allow full visibility, ... access to the work area. Includes ...
... Label IT siRNA Tracker Intracellular Localization ... a straight forward approach to directly ... design, in an efficient yet non-destructive ... Subcellular localization and functional inhibition of ...
Biology Products: